Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2017 Filed May 22, 2017 21:02 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021759 · doc1.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,969 F1 · shares: Mr. Muir was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:01 UTC |
Cox JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,434 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001140361-17-021758 · doc1.xml · derivative · entry 2 Cox John · CIK 0001498428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434 Underlying: Common Stock · 2,434 shares Expires 2027-05-18 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 18, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:01 UTC |
Cox JohnDirector
|
GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021758 · doc1.xml · nonDerivative · entry 1 Cox John · CIK 0001498428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,827 F1 · shares: Mr. Cox was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:00 UTC |
COOPER GLENN L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,434 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001140361-17-021757 · doc1.xml · derivative · entry 2 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434 Underlying: Common Stock · 2,434 shares Expires 2027-05-18 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 18, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:00 UTC |
COOPER GLENN L MDDirector
|
GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021757 · doc1.xml · nonDerivative · entry 1 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,300 F1 · shares: Dr. Cooper was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 18, 2017 Filed May 22, 2017 20:56 UTC |
BARTHELEMY NICOLASDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,434 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001140361-17-021756 · doc1.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434 Underlying: Common Stock · 2,434 shares Expires 2027-05-18 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 18, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 20:56 UTC |
BARTHELEMY NICOLASDirector
|
GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021756 · doc1.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,988 F1 · shares: Mr. Barthelemy was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 18, 2017 Filed May 22, 2017 20:56 UTC |
DAWES KAREN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,459 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001140361-17-021755 · doc1.xml · derivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,459 Underlying: Common Stock · 3,459 shares Expires 2027-05-18 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 18, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 20:56 UTC |
DAWES KAREN ADirector
|
GrantCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021755 · doc1.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,957 F1 · shares: Ms. Dawes was awarded 1,714 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 10, 2017 Filed May 11, 2017 20:57 UTC |
Hunt AnthonyChief Executive Officer
|
Tax withholdingCommon Stock | 2,275 | $37.97 | $86,392.90 |
DisclosureSEC source: 0001140361-17-019804 · doc1.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,583 F1 · shares: Payment of tax liability made via forfeiture of 2,275 shares of Common Stock valued at a weighted average price of $37.9749 per share on May 10, 2017. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:37 UTC |
RYAN THOMAS F JRDirector
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014158 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,494 Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:37 UTC |
RYAN THOMAS F JRDirector
|
GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014158 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,844 Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 21:20 UTC |
DAWES KAREN ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.29 | $0.00 |
DisclosureSEC source: 0001140361-17-012956 · doc1.xml · derivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 21:20 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 2,521 | $34.12 | $86,016.77 |
DisclosureSEC source: 0001140361-17-012956 · doc1.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,243 F1 · price: $34.1201 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 21:20 UTC |
DAWES KAREN ADirector
|
Exercise / conversionCommon Stock | 20,000 | $4.29 | $85,800.00 |
DisclosureSEC source: 0001140361-17-012956 · doc1.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC |
RYAN THOMAS F JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · derivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 4,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC |
RYAN THOMAS F JRDirector
|
SaleCommon Stock | 4,000 | $34.83 | $139,321.20 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,594 F1 · price: $34.8303 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC |
RYAN THOMAS F JRDirector
|
Exercise / conversionCommon Stock | 4,000 | $3.22 | $12,880.00 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · derivative · entry 6 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,968 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · derivative · entry 5 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,968 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
Exercise / conversionCommon Stock | 10,000 | $6.23 | $62,300.00 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · nonDerivative · entry 4 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
SaleCommon Stock | 7,248 | $34.63 | $251,009.84 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · nonDerivative · entry 3 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,908 F2 · price: $34.6316 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
SaleCommon Stock | 4,968 | $34.61 | $171,943.97 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · nonDerivative · entry 2 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,156 F1 · price: $34.6103 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:41 UTC |
Benjamin HowardVP Business Development
|
Exercise / conversionCommon Stock | 4,968 | $15.91 | $79,040.88 |
DisclosureSEC source: 0001140361-17-012940 · doc1.xml · nonDerivative · entry 1 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2017 Filed Mar 22, 2017 01:03 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $24.50 | $0.00 |
DisclosureSEC source: 0001140361-17-012886 · doc1.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 4,000 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019. Read SEC document |
| March 17, 2017 Filed Mar 22, 2017 01:03 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionCommon Stock | 4,000 | $24.50 | $98,000.00 |
DisclosureSEC source: 0001140361-17-012886 · doc1.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2017 Filed Mar 22, 2017 01:03 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 1,909 | $34.91 | $66,646.05 |
DisclosureSEC source: 0001140361-17-012886 · doc1.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,789 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 02:00 UTC |
Benjamin HowardVP Business Development
|
Tax withholdingCommon Stock | 1,976 | $32.08 | $63,387.31 |
DisclosureSEC source: 0001140361-17-010119 · doc1.xml · nonDerivative · entry 2 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,156 F2 · shares: Payment of tax liability made via forfeiture of 1,976 shares of Common Stock valued at a weighted average of $32.0786 per share on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 01:57 UTC |
Snodgres JonChief Financial Officer
|
Tax withholdingCommon Stock | 1,630 | $32.07 | $52,272.96 |
DisclosureSEC source: 0001140361-17-010118 · doc1.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,698 F2 · shares: Payment of tax liability made via forfeiture of 1,630 shares of Common Stock valued at a weighted average price of $32.0693 per share on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 01:56 UTC |
Hunt AnthonyChief Executive Officer
|
Tax withholdingCommon Stock | 5,972 | $32.07 | $191,524.43 |
DisclosureSEC source: 0001140361-17-010117 · doc1.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,858 F2 · shares: Payment of tax liability made via forfeiture of 5,972 shares of Common Stock valued at a weighted average price of $32.0704 per share on March 1, 2017. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 02:00 UTC |
Benjamin HowardVP Business Development
|
GrantStock Option (Right to Buy) · Derivative | 9,012 | $0.00 Strike: $32.32 | $0.00 |
DisclosureSEC source: 0001140361-17-010119 · doc1.xml · derivative · entry 3 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 Underlying: Common Stock · 9,012 shares Expires 2027-02-23 F3 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 02:00 UTC |
Benjamin HowardVP Business Development
|
GrantCommon Stock | 4,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010119 · doc1.xml · nonDerivative · entry 1 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,132 F1 · shares: Mr. Benjamin was awarded 4,506 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 01:57 UTC |
Snodgres JonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 19,750 | $0.00 Strike: $32.32 | $0.00 |
DisclosureSEC source: 0001140361-17-010118 · doc1.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,750 Underlying: Common Stock · 19,750 shares Expires 2027-02-23 F3 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 01:57 UTC |
Snodgres JonChief Financial Officer
|
GrantCommon Stock | 9,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010118 · doc1.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,328 F1 · shares: Mr. Snodgres was awarded 9,875 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 01:56 UTC |
Hunt AnthonyChief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 64,975 | $0.00 Strike: $32.32 | $0.00 |
DisclosureSEC source: 0001140361-17-010117 · doc1.xml · derivative · entry 3 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,975 Underlying: Common Stock · 64,975 shares Expires 2027-02-23 F3 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 01:56 UTC |
Hunt AnthonyChief Executive Officer
|
GrantCommon Stock | 32,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010117 · doc1.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,830 F1 · shares: Mr. Hunt was awarded 32,488 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 23, 2017 Filed Mar 22, 2017 00:23 UTC Amendment |
Benjamin HowardVP Business Development
|
GrantStock Option (Right to Buy) · Derivative | 9,012 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0001140361-17-012884 · doc1.xml · derivative · entry 1 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 Underlying: Common Stock · 9,012 shares Expires 2027-02-23 F1 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Mar 22, 2017 00:22 UTC Amendment |
Snodgres JonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 19,750 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0001140361-17-012883 · doc1.xml · derivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,750 Underlying: Common Stock · 19,750 shares Expires 2027-02-23 F1 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Mar 22, 2017 00:22 UTC Amendment |
Hunt AnthonyChief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 64,975 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0001140361-17-012882 · doc1.xml · derivative · entry 1 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,975 Underlying: Common Stock · 64,975 shares Expires 2027-02-23 F1 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed May 22, 2017 21:12 UTC Amendment |
Snodgres JonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,165 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0001140361-17-021770 · doc1.xml · derivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,165 Underlying: Common Stock · 18,165 shares Expires 2027-02-23 F1 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed May 22, 2017 21:15 UTC Amendment |
Benjamin HowardVP Business Development
|
GrantStock Option (Right to Buy) · Derivative | 8,289 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0001140361-17-021773 · doc1.xml · derivative · entry 1 Benjamin Howard · CIK 0001393547 · VP Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,289 Underlying: Common Stock · 8,289 shares Expires 2027-02-23 F1 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| December 23, 2016 Filed Feb 15, 2017 00:45 UTC |
RUSCHE JAMES RSENIOR VICE PRESIDENT
|
GiftCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-004086 · doc5.xml · nonDerivative · entry 1 RUSCHE JAMES R · CIK 0001241031 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,816 Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 21:58 UTC |
Hunt AnthonyChief Executive Officer
|
SaleCommon Stock | 5,000 | $33.12 | $165,613.00 |
DisclosureSEC source: 0001140361-16-088077 · doc1.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,342 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: $33.1226 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.84 to $33.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:20 UTC |
RYAN THOMAS F JRDirector
|
SaleCommon Stock | 2,700 | $32.58 | $87,978.69 |
DisclosureSEC source: 0001140361-16-080002 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394 Read SEC document |
| August 24, 2016 Filed Feb 15, 2017 00:48 UTC |
RYAN THOMAS F JRDirector
|
GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-004088 · doc5.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,594 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.